NCT01102426 · BASELINE

Baseline characteristics

Aplidin - Dexamethasone in Relapsed/Refractory Myeloma · Source last updated 2020-11-10

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants

groups

description
plitidepsin + dexamethasone combination plitidepsin + dexamethasone: plitidepsin: powder and solvent for concentrate for solution for infusion. 2 mg vial + 4 ml ampoule. 5 mg/m2 intravenously (i.v.) over three hours on Day 1 and 15 every 4 weeks. dexamethasone: 4 mg tablet. 40 mg orally on Day 1, 8, 15 and 22 every four weeks at least one hour before plitidepsin infusion.
id
BG000
title
Plitidepsin+Dexamethasone
description
dexamethasone single agent dexamethasone: 4 mg tablet. 40 mg orally on Day 1, 8, 15 and 22 every four weeks.
id
BG001
title
Dexamethasone
description
Total of all reporting groups
id
BG002
title
Total

measures

classes
categories
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
<=18 years
measurements
group Id
BG000
value
88
group Id
BG001
value
36
group Id
BG002
value
124
title
Between 18 and 65 years
measurements
group Id
BG000
value
83
group Id
BG001
value
48
group Id
BG002
value
131
title
>=65 years
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
param Type
COUNT_OF_PARTICIPANTS
title
Age, Categorical
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
lower Limit
36
upper Limit
85
value
64
group Id
BG001
lower Limit
42
upper Limit
85
value
65
group Id
BG002
lower Limit
36
upper Limit
85
value
65
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
dispersion Type
FULL_RANGE
param Type
MEDIAN
title
Age, Continuous
unit Of Measure
years
classes
categories
measurements
group Id
BG000
value
74
group Id
BG001
value
49
group Id
BG002
value
123
title
Female
measurements
group Id
BG000
value
97
group Id
BG001
value
35
group Id
BG002
value
132
title
Male
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
param Type
COUNT_OF_PARTICIPANTS
title
Sex: Female, Male
unit Of Measure
Participants
classes
categories
measurements
group Id
BG002
value
0
denoms
counts
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
units
Participants
param Type
COUNT_OF_PARTICIPANTS
population Description
Race and Ethnicity were not collected from any participant.
title
Race and Ethnicity Not Collected
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
6
group Id
BG001
value
1
group Id
BG002
value
7
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
title
United States
categories
measurements
group Id
BG000
value
23
group Id
BG001
value
10
group Id
BG002
value
33
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
title
Czechia
categories
measurements
group Id
BG000
value
12
group Id
BG001
value
6
group Id
BG002
value
18
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
title
United Kingdom
categories
measurements
group Id
BG000
value
2
group Id
BG001
value
1
group Id
BG002
value
3
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
title
Portugal
categories
measurements
group Id
BG000
value
13
group Id
BG001
value
7
group Id
BG002
value
20
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
title
Spain
categories
measurements
group Id
BG000
value
12
group Id
BG001
value
7
group Id
BG002
value
19
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
title
Greece
categories
measurements
group Id
BG000
value
7
group Id
BG001
value
1
group Id
BG002
value
8
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
title
New Zealand
categories
measurements
group Id
BG000
value
21
group Id
BG001
value
7
group Id
BG002
value
28
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
title
Austria
categories
measurements
group Id
BG000
value
8
group Id
BG001
value
4
group Id
BG002
value
12
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
title
South Korea
categories
measurements
group Id
BG000
value
5
group Id
BG001
value
4
group Id
BG002
value
9
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
title
Netherlands
param Type
COUNT_OF_PARTICIPANTS
title
Region of Enrollment
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
68
group Id
BG001
value
31
group Id
BG002
value
99
title
PS 0
measurements
group Id
BG000
value
74
group Id
BG001
value
42
group Id
BG002
value
116
title
PS 1
measurements
group Id
BG000
value
28
group Id
BG001
value
11
group Id
BG002
value
39
title
PS 2
measurements
group Id
BG000
value
1
group Id
BG001
value
0
group Id
BG002
value
1
title
PS 3
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
description
ECOG PS, Eastern Cooperative Oncology Group performance status PS 0 Fully active, able to carry on all pre-disease performance without restriction PS 1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature PS 2 Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours PS 3 Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours PS 4 Completely disabled; cannot carry on any selfcare; totally confined to bed or chair PS 5 Dead
param Type
COUNT_OF_PARTICIPANTS
title
ECOG PS
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
6
group Id
BG001
value
1
group Id
BG002
value
7
title
Non Secretory
measurements
group Id
BG000
value
35
group Id
BG001
value
21
group Id
BG002
value
56
title
Secretory IgA
measurements
group Id
BG000
value
1
group Id
BG001
value
1
group Id
BG002
value
2
title
Secretory IgD
measurements
group Id
BG000
value
101
group Id
BG001
value
51
group Id
BG002
value
152
title
Secretory IgG
measurements
group Id
BG000
value
1
group Id
BG001
value
0
group Id
BG002
value
1
title
Secretory IgM
measurements
group Id
BG000
value
27
group Id
BG001
value
10
group Id
BG002
value
37
title
Secretory Light chain disease
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
param Type
COUNT_OF_PARTICIPANTS
title
MM type at diagnosis
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
0
group Id
BG001
value
1
group Id
BG002
value
1
title
Stage A
measurements
group Id
BG000
value
21
group Id
BG001
value
9
group Id
BG002
value
30
title
Stage IA
measurements
group Id
BG000
value
0
group Id
BG001
value
2
group Id
BG002
value
2
title
Stage IB
measurements
group Id
BG000
value
3
group Id
BG001
value
1
group Id
BG002
value
4
title
Stage II
measurements
group Id
BG000
value
44
group Id
BG001
value
20
group Id
BG002
value
64
title
Stage IIA
measurements
group Id
BG000
value
1
group Id
BG001
value
0
group Id
BG002
value
1
title
Stage IIB
measurements
group Id
BG000
value
2
group Id
BG001
value
1
group Id
BG002
value
3
title
Stage III
measurements
group Id
BG000
value
85
group Id
BG001
value
43
group Id
BG002
value
128
title
Stage IIIA
measurements
group Id
BG000
value
14
group Id
BG001
value
7
group Id
BG002
value
21
title
Stage IIIB
measurements
group Id
BG000
value
1
group Id
BG001
value
0
group Id
BG002
value
1
title
Not Durie-Salmon stage at diagnosis
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
description
Stage I: small number of myeloma cells. All are present:Hemoglobin\>100 g/L;Blood calcium\<2.8 mmol/L;No areas of bone damage or a solitary plasmacytoma of the bone;IgG\<50 g/L;IgA\<30 g/L;Urine M-protein\<4 g Stage II: Moderate number of myeloma cells. The features are between stage 1 and 3 Stage III: Large number of myeloma cells. One/more are present: Hemoglobin\<85 g/L;Blood calcium\>2.8 mmol/L;Several areas of bone damage;IgG\>70 g/L;IgA\>50 g/L;Urine M-protein\>12 g Substage A: Kidney function is normal. Creatinine\<180 µmol/L. Substage B: Kidney function is abnormal. Creatinine\>=180 µmol/L
param Type
COUNT_OF_PARTICIPANTS
title
Durie-Salmon stage at diagnosis
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
72
group Id
BG001
value
33
group Id
BG002
value
105
title
Stage I
measurements
group Id
BG000
value
41
group Id
BG001
value
18
group Id
BG002
value
59
title
Stage II
measurements
group Id
BG000
value
23
group Id
BG001
value
15
group Id
BG002
value
38
title
Stage III
measurements
group Id
BG000
value
35
group Id
BG001
value
18
group Id
BG002
value
53
title
Not stage at diagnosis
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
description
The International Staging System uses the results of 2 blood tests: albumin and beta-2-microglobulin level. Stage I: Beta-2-microglobulin level less than 3.5 mg/L and albumin level more equal than 35 g/L. Stage II: Beta-2-microglobulin level less than 3.5 mg/L and Albumin level less than 35 g/L or beta-2-microglobulin level is more than 3.5 mg/L but less than 5.5 mg/L and any albumin level. Stage III: Beta-2-microglobulin is 5.5 mg/L or more and any albumin level.
param Type
COUNT_OF_PARTICIPANTS
title
International Staging System at diagnosis
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
34
group Id
BG001
value
21
group Id
BG002
value
55
title
Standard risk
measurements
group Id
BG000
value
38
group Id
BG001
value
16
group Id
BG002
value
54
title
High risk
measurements
group Id
BG000
value
99
group Id
BG001
value
47
group Id
BG002
value
146
title
NA/ND/UK
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
description
NA: not available; ND: not done; UK: unknown.
param Type
COUNT_OF_PARTICIPANTS
title
Cytogenetic risk group at diagnosis
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
68
group Id
BG001
value
35
group Id
BG002
value
103
title
Yes
measurements
group Id
BG000
value
103
group Id
BG001
value
49
group Id
BG002
value
152
title
No
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
param Type
COUNT_OF_PARTICIPANTS
title
Prior radiotherapy
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
lower Limit
7
upper Limit
14.6
value
10.4
group Id
BG001
lower Limit
7.4
upper Limit
14.6
value
10.1
group Id
BG002
lower Limit
7
upper Limit
14.6
value
10.3
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
dispersion Type
FULL_RANGE
param Type
MEDIAN
title
Hb
unit Of Measure
g/dL

Complete source fields

denoms

counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants

groups

description
plitidepsin + dexamethasone combination plitidepsin + dexamethasone: plitidepsin: powder and solvent for concentrate for solution for infusion. 2 mg vial + 4 ml ampoule. 5 mg/m2 intravenously (i.v.) over three hours on Day 1 and 15 every 4 weeks. dexamethasone: 4 mg tablet. 40 mg orally on Day 1, 8, 15 and 22 every four weeks at least one hour before plitidepsin infusion.
id
BG000
title
Plitidepsin+Dexamethasone
description
dexamethasone single agent dexamethasone: 4 mg tablet. 40 mg orally on Day 1, 8, 15 and 22 every four weeks.
id
BG001
title
Dexamethasone
description
Total of all reporting groups
id
BG002
title
Total

measures

classes
categories
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
<=18 years
measurements
group Id
BG000
value
88
group Id
BG001
value
36
group Id
BG002
value
124
title
Between 18 and 65 years
measurements
group Id
BG000
value
83
group Id
BG001
value
48
group Id
BG002
value
131
title
>=65 years
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
param Type
COUNT_OF_PARTICIPANTS
title
Age, Categorical
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
lower Limit
36
upper Limit
85
value
64
group Id
BG001
lower Limit
42
upper Limit
85
value
65
group Id
BG002
lower Limit
36
upper Limit
85
value
65
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
dispersion Type
FULL_RANGE
param Type
MEDIAN
title
Age, Continuous
unit Of Measure
years
classes
categories
measurements
group Id
BG000
value
74
group Id
BG001
value
49
group Id
BG002
value
123
title
Female
measurements
group Id
BG000
value
97
group Id
BG001
value
35
group Id
BG002
value
132
title
Male
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
param Type
COUNT_OF_PARTICIPANTS
title
Sex: Female, Male
unit Of Measure
Participants
classes
categories
measurements
group Id
BG002
value
0
denoms
counts
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
units
Participants
param Type
COUNT_OF_PARTICIPANTS
population Description
Race and Ethnicity were not collected from any participant.
title
Race and Ethnicity Not Collected
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
6
group Id
BG001
value
1
group Id
BG002
value
7
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
title
United States
categories
measurements
group Id
BG000
value
23
group Id
BG001
value
10
group Id
BG002
value
33
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
title
Czechia
categories
measurements
group Id
BG000
value
12
group Id
BG001
value
6
group Id
BG002
value
18
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
title
United Kingdom
categories
measurements
group Id
BG000
value
2
group Id
BG001
value
1
group Id
BG002
value
3
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
title
Portugal
categories
measurements
group Id
BG000
value
13
group Id
BG001
value
7
group Id
BG002
value
20
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
title
Spain
categories
measurements
group Id
BG000
value
12
group Id
BG001
value
7
group Id
BG002
value
19
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
title
Greece
categories
measurements
group Id
BG000
value
7
group Id
BG001
value
1
group Id
BG002
value
8
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
title
New Zealand
categories
measurements
group Id
BG000
value
21
group Id
BG001
value
7
group Id
BG002
value
28
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
title
Austria
categories
measurements
group Id
BG000
value
8
group Id
BG001
value
4
group Id
BG002
value
12
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
title
South Korea
categories
measurements
group Id
BG000
value
5
group Id
BG001
value
4
group Id
BG002
value
9
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
title
Netherlands
param Type
COUNT_OF_PARTICIPANTS
title
Region of Enrollment
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
68
group Id
BG001
value
31
group Id
BG002
value
99
title
PS 0
measurements
group Id
BG000
value
74
group Id
BG001
value
42
group Id
BG002
value
116
title
PS 1
measurements
group Id
BG000
value
28
group Id
BG001
value
11
group Id
BG002
value
39
title
PS 2
measurements
group Id
BG000
value
1
group Id
BG001
value
0
group Id
BG002
value
1
title
PS 3
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
description
ECOG PS, Eastern Cooperative Oncology Group performance status PS 0 Fully active, able to carry on all pre-disease performance without restriction PS 1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature PS 2 Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours PS 3 Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours PS 4 Completely disabled; cannot carry on any selfcare; totally confined to bed or chair PS 5 Dead
param Type
COUNT_OF_PARTICIPANTS
title
ECOG PS
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
6
group Id
BG001
value
1
group Id
BG002
value
7
title
Non Secretory
measurements
group Id
BG000
value
35
group Id
BG001
value
21
group Id
BG002
value
56
title
Secretory IgA
measurements
group Id
BG000
value
1
group Id
BG001
value
1
group Id
BG002
value
2
title
Secretory IgD
measurements
group Id
BG000
value
101
group Id
BG001
value
51
group Id
BG002
value
152
title
Secretory IgG
measurements
group Id
BG000
value
1
group Id
BG001
value
0
group Id
BG002
value
1
title
Secretory IgM
measurements
group Id
BG000
value
27
group Id
BG001
value
10
group Id
BG002
value
37
title
Secretory Light chain disease
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
param Type
COUNT_OF_PARTICIPANTS
title
MM type at diagnosis
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
0
group Id
BG001
value
1
group Id
BG002
value
1
title
Stage A
measurements
group Id
BG000
value
21
group Id
BG001
value
9
group Id
BG002
value
30
title
Stage IA
measurements
group Id
BG000
value
0
group Id
BG001
value
2
group Id
BG002
value
2
title
Stage IB
measurements
group Id
BG000
value
3
group Id
BG001
value
1
group Id
BG002
value
4
title
Stage II
measurements
group Id
BG000
value
44
group Id
BG001
value
20
group Id
BG002
value
64
title
Stage IIA
measurements
group Id
BG000
value
1
group Id
BG001
value
0
group Id
BG002
value
1
title
Stage IIB
measurements
group Id
BG000
value
2
group Id
BG001
value
1
group Id
BG002
value
3
title
Stage III
measurements
group Id
BG000
value
85
group Id
BG001
value
43
group Id
BG002
value
128
title
Stage IIIA
measurements
group Id
BG000
value
14
group Id
BG001
value
7
group Id
BG002
value
21
title
Stage IIIB
measurements
group Id
BG000
value
1
group Id
BG001
value
0
group Id
BG002
value
1
title
Not Durie-Salmon stage at diagnosis
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
description
Stage I: small number of myeloma cells. All are present:Hemoglobin\>100 g/L;Blood calcium\<2.8 mmol/L;No areas of bone damage or a solitary plasmacytoma of the bone;IgG\<50 g/L;IgA\<30 g/L;Urine M-protein\<4 g Stage II: Moderate number of myeloma cells. The features are between stage 1 and 3 Stage III: Large number of myeloma cells. One/more are present: Hemoglobin\<85 g/L;Blood calcium\>2.8 mmol/L;Several areas of bone damage;IgG\>70 g/L;IgA\>50 g/L;Urine M-protein\>12 g Substage A: Kidney function is normal. Creatinine\<180 µmol/L. Substage B: Kidney function is abnormal. Creatinine\>=180 µmol/L
param Type
COUNT_OF_PARTICIPANTS
title
Durie-Salmon stage at diagnosis
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
72
group Id
BG001
value
33
group Id
BG002
value
105
title
Stage I
measurements
group Id
BG000
value
41
group Id
BG001
value
18
group Id
BG002
value
59
title
Stage II
measurements
group Id
BG000
value
23
group Id
BG001
value
15
group Id
BG002
value
38
title
Stage III
measurements
group Id
BG000
value
35
group Id
BG001
value
18
group Id
BG002
value
53
title
Not stage at diagnosis
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
description
The International Staging System uses the results of 2 blood tests: albumin and beta-2-microglobulin level. Stage I: Beta-2-microglobulin level less than 3.5 mg/L and albumin level more equal than 35 g/L. Stage II: Beta-2-microglobulin level less than 3.5 mg/L and Albumin level less than 35 g/L or beta-2-microglobulin level is more than 3.5 mg/L but less than 5.5 mg/L and any albumin level. Stage III: Beta-2-microglobulin is 5.5 mg/L or more and any albumin level.
param Type
COUNT_OF_PARTICIPANTS
title
International Staging System at diagnosis
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
34
group Id
BG001
value
21
group Id
BG002
value
55
title
Standard risk
measurements
group Id
BG000
value
38
group Id
BG001
value
16
group Id
BG002
value
54
title
High risk
measurements
group Id
BG000
value
99
group Id
BG001
value
47
group Id
BG002
value
146
title
NA/ND/UK
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
description
NA: not available; ND: not done; UK: unknown.
param Type
COUNT_OF_PARTICIPANTS
title
Cytogenetic risk group at diagnosis
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
68
group Id
BG001
value
35
group Id
BG002
value
103
title
Yes
measurements
group Id
BG000
value
103
group Id
BG001
value
49
group Id
BG002
value
152
title
No
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
param Type
COUNT_OF_PARTICIPANTS
title
Prior radiotherapy
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
lower Limit
7
upper Limit
14.6
value
10.4
group Id
BG001
lower Limit
7.4
upper Limit
14.6
value
10.1
group Id
BG002
lower Limit
7
upper Limit
14.6
value
10.3
denoms
counts
group Id
BG000
value
171
group Id
BG001
value
84
group Id
BG002
value
255
units
Participants
dispersion Type
FULL_RANGE
param Type
MEDIAN
title
Hb
unit Of Measure
g/dL

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice